Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons

Autor: Bruisten, S. M., Reiss, P., Loeliger, A. E., van Swieten, P., Schuurman, R., Boucher, C. A., Weverling, G. J., Huisman, J. G.

Publikováno v: AIDS research and human retroviruses, 14(12), 1053-1058. Mary Ann Liebert Inc.

In a set of 42 antiretroviral naive HIV-1 infected persons who were treated with either Zidovudine (AZT) monotherapy, or a combination of AZT + ddC (Zalcitabine) or AZT + ddI (Didanosine), the HIV-1 DNA load was measured by competitive polymerase cha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::5291be636e27986910d53309ace4d039
https://pure.amc.nl/en/publications/cellular-proviral-hiv-type-1-dna-load-persists-after-longterm-rtinhibitor-therapy-in-hiv-type-1-infected-persons(eafbe764-2ecf-43b3-80e5-df20faa36a06).html

Optimal symptom combinations to aid COVID-19 case identification: analysis from a community-based, prospective, observational cohort.

Autor: Antonelli M; School of Biomedical Engineering & Imaging Sciences, King's College London, London, UK., Capdevila J; Zoe Global, London, UK., Chaudhari A; Coalition for Epidemic Preparedness Innovations, London, UK., Granerod J; Coalition for Epidemic Preparedness Innovations, London, UK., Canas LS; School of Biomedical Engineering & Imaging Sciences, King's College London, London, UK., Graham MS; School of Biomedical Engineering & Imaging Sciences, King's College London, London, UK., Klaser K; School of Biomedical Engineering & Imaging Sciences, King's College London, London, UK., Modat M; School of Biomedical Engineering & Imaging Sciences, King's College London, London, UK., Molteni E; School of Biomedical Engineering & Imaging Sciences, King's College London, London, UK., Murray B; School of Biomedical Engineering & Imaging Sciences, King's College London, London, UK., Sudre CH; MRC Unit for Lifelong Health and Ageing at UCL/Centre for Medical Image Computing, Department of Computer Science, UCL, London, UK.; School of Biomedical Engineering & Imaging Sciences, King's College London, London, UK., Davies R; Zoe Global, London, UK., May A; Zoe Global, London, UK., Nguyen LH; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Drew DA; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Joshi A; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Chan AT; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Cramer JP; Coalition for Epidemic Preparedness Innovations, London, UK., Spector T; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK., Wolf J; Zoe Global, London, UK., Ourselin S; School of Biomedical Engineering & Imaging Sciences, King's College London, London, UK., Steves CJ; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK., Loeliger AE; Coalition for Epidemic Preparedness Innovations, London, UK.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2021 Feb 08. Date of Electronic Publication: 2021 Feb 08.

The abacavir hypersensitivity reaction and interruptions in therapy.

Autor: Loeliger AE, Steel H, McGuirk S, Powell WS, Hetherington SV

Publikováno v: AIDS (London, England) [AIDS] 2001 Jul 06; Vol. 15 (10), pp. 1325-6.

Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively.

Autor: van't Wout AB; Department of Clinical Viro-Immunology, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, University of Amsterdam, The Netherlands., Ran LJ, de Jong MD, Bakker M, van Leeuwen R, Notermans DW, Loeliger AE, de Wolf F, Danner SA, Reiss P, Boucher CA, Lange JM, Schuitemaker H

Publikováno v: The Journal of clinical investigation [J Clin Invest] 1997 Nov 01; Vol. 100 (9), pp. 2325-32.

Use of competitive polymerase chain reaction to determine HIV-1 levels in response to antiviral treatments.

Autor: Bruisten SM; Central Laboratory, The Netherlands Red Cross Blood Transfusion Service, Amsterdam., Koppelman MH, Roos MT, Loeliger AE, Reiss P, Boucher CA, Huisman HG

Publikováno v: AIDS (London, England) [AIDS] 1993 Nov; Vol. 7 Suppl 2, pp. S15-20.